Dickran Kazandjian, Md

This study is testing whether adding a new drug called linvoseltamab to standard lenalidomide maintenance therapy can help eliminate any remaining cancer cells in people with multiple myeloma. Researchers want to see if this combination can help patients achieve and maintain 'min…